The J.M. Smucker Company stocks have been trading up by 12.93 percent amid heightened optimism from the most impactful earnings news.
Key Takeaways
- UBS lowered its price target but kept a Buy on SJM, still seeing organic growth and strong profits ahead even as food names battle softer demand and inflation.
- RBC Capital expects SJM’s fiscal Q4 and 2027 outlook to land roughly in line, pointing to strong coffee, weaker pet, and mixed frozen and spreads, and pegs fair value at $130 versus about $102.50.
- Morgan Stanley nudged its SJM target to $106 and calls the name the best‑screening in its group with the least earnings revision risk, despite trimming 2027 EPS estimates.
- Street consensus on SJM sits around Overweight with a $116–$116.50 target range, well above the low‑$100s share price.
- Traders are watching SJM’s next print closely, with Wall Street eyeing $2.64 EPS as the key line in the sand for this off‑cycle earnings release.
Live Update At 11:31:58 EDT: On Tuesday, June 09, 2026 The J.M. Smucker Company stock [NYSE: SJM] is trending up by 12.93%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
SJM has shifted from sleepy to active on the tape. Over the past few weeks, The J.M. Smucker Company has bounced from roughly $100 into the mid‑$110s, with the latest daily candle closing near $115 after a strong push from an open just under $107. That kind of 7–8% intraday surge in SJM is not normal for a packaged‑food name; it tells traders that expectations into earnings and new analyst calls are finally moving the stock.
Zooming out, the daily chart shows SJM grinding sideways around $100–$104 for several sessions before this breakout day. That base matters. It tells traders that weak hands may have been shaken out before the spike, creating cleaner momentum for any follow‑through.
More Breaking News
- SharkNinja Stock Pops As S&P MidCap 400 Inclusion Fuels Momentum
- Everest Group Ltd. Stock Rises as AIG Deal Sharpens Focus
- Nuvalent (NUVL) Soars On GSK Deal Buzz And FDA Momentum
- CBRS Stock Rockets After Blockbuster AI Infrastructure IPO
Fundamentally, the picture is more complicated. SJM is posting solid revenue around $8.7B with a healthy 33.6% gross margin, but the latest quarter showed a big net loss, driven in large part by an almost $962M impairment charge. That’s an accounting hit, not a cash drain, but it drags margins and returns negative. On the cash side, SJM still printed about $487M in free cash flow and pays a dividend around 4.3%, while carrying meaningful leverage with debt‑to‑equity near 1.4 and interest coverage thin. For traders, that mix says “cash‑rich but debt‑heavy,” with the chart now leading the story.
Why Traders Are Watching SJM Now
Right now SJM is one of those slow names that suddenly has a fast tape. On 2026/06/09, the stock ripped from the high‑$100s to over $115, and the intraday 5‑minute chart shows steady stair‑step buying from the open. Early buyers grabbed SJM near $107; dip buyers stepped in around $112–$113; and into late morning, sellers were getting run over as the stock pushed to fresh highs around $115. That’s classic momentum behavior in a normally defensive brand.
What’s driving it? A cluster of supportive analyst calls. UBS trimmed its SJM target to $121 from $132 but kept a Buy and called the company a partial exception in a weak packaged‑foods group. UBS still sees a “credible path” to organic growth and better profits over the next 12–18 months. In trader language, that’s “sector trash, stock hold.”
RBC is even more upbeat on SJM. The firm expects fiscal Q4 numbers and 2027 guidance to land broadly in line, with coffee strength offsetting softer pet and mixed frozen handhelds and spreads. RBC’s $130 target versus roughly $102.50 spot pricing spells out serious upside if SJM simply executes.
Morgan Stanley plays the skeptic role, yet still raised its target to $106 and calls SJM the best‑screening name in its group, with the least earnings‑revision risk despite trimming 2027 EPS estimates. When the most cautious big house still sees SJM as relatively strong, traders pay attention.
Layer on consensus targets around $116–$116.50 and a Street EPS bar of $2.64 for the upcoming report, and you get a tight setup: a defensive stock with positive bias, just broken out technically, heading straight into a catalyst.
Conclusion
For active traders, SJM now sits at the intersection of chart momentum and fundamental debate. The J.M. Smucker Company is still digesting heavy non‑cash charges that torched recent GAAP earnings, yet it continues to throw off strong operating cash flow and fund a healthy dividend. Debt is not small, and interest coverage is thin, so this is not a no‑risk story. But with free cash flow strong and major brokers framing SJM as a standout in a pressured sector, the market is starting to price in stabilization rather than collapse.
Short term, the key battleground is that $2.64 EPS expectation. A clean beat with steady 2027 guidance can justify UBS’s and RBC’s upside targets and keep SJM holding above the $110 breakout zone. A miss or soft outlook, and traders who chased the spike toward $115 may find themselves trapped, exactly the type of emotional overreach professionals look to fade.
This is where discipline matters. As Tim Sykes likes to say, “Rule number one is cutting losses quickly. Rule number two is don’t forget rule number one.” As millionaire penny stock trader and teacher Tim Sykes says, “The goal is not to win every trade but to protect your capital and keep moving forward.”. For SJM, that means respecting support and resistance, trading the reaction to earnings instead of the prediction, and letting the price action confirm whether this new uptrend is for real or just another head fake in a choppy, inflation‑hit food tape. This content is for educational and research purposes only and is not investment advice.
This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.
Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:
- Penny Stocks Trading Guide
- Best Penny Stocks Under $1 to Buy Today
- Top 8 Penny Stocks to Watch on Robinhood
Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:
Leave a reply